BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 2317761)

  • 1. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.
    Duk JM; De Bruijn HW; Groenier KH; Fleuren GJ; Aalders JG
    Cancer; 1990 Apr; 65(8):1830-7. PubMed ID: 2317761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
    Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
    Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
    Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
    J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancer.
    Picardo AL; Torres AJ; Maestro M; Ortega D; Garcia-Asenjo JA; Mugüerza JM; Hernando F; Diez M; Balibrea JL
    Cancer; 1994 May; 73(9):2305-11. PubMed ID: 8168034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
    Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.
    Avall-Lundqvist EH; Sjövall K; Nilsson BR; Eneroth PH
    Eur J Cancer; 1992; 28A(10):1695-702. PubMed ID: 1389488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
    Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical study on CA 15-3, CEA, SCC-Ag in patients with squamous cell carcinoma of the lung].
    Moriya H; Suzuki S; Aizumi J; Kimura K; Urabe S; Higuci Y; Hoshi K
    Rinsho Hoshasen; 1989 Jan; 34(1):63-6. PubMed ID: 2724610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum.
    Aalders JG; de Bruijn HW; Oosterhuis JW; Duk JM
    Gynecol Oncol; 1990 Jan; 36(1):110-2. PubMed ID: 2295441
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.
    de Bruijn HW; Duk JM; van der Zee AG; Pras E; Willemse PH; Boonstra H; Hollema H; Mourits MJ; de Vries EG; Aalders JG
    Tumour Biol; 1998; 19(6):505-16. PubMed ID: 9817980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor markers carcinoembryonic antigen, CA 50, and CA 19-9 and squamous cell carcinoma of the esophagus. Pretreatment screening.
    Munck-Wikland E; Kuylenstierna R; Wahren B; Lindholm J; Haglund S
    Cancer; 1988 Dec; 62(11):2281-6. PubMed ID: 3179942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of preoperative tumor marker levels and lymphovascular invasion in pathological stage I adenocarcinoma and squamous cell carcinoma of the lung.
    Kinoshita T; Ohtsuka T; Yotsukura M; Asakura K; Goto T; Kamiyama I; Otake S; Tajima A; Emoto K; Hayashi Y; Kohno M
    J Thorac Oncol; 2015 Apr; 10(4):619-28. PubMed ID: 25634009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix.
    Lehtovirta P; Viinikka L; Ylikorkala O
    Gynecol Oncol; 1990 May; 37(2):276-8. PubMed ID: 2344974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix.
    Ikeda S; Yoshimura K; Onda T; Kasamatsu T; Kato T; Ishikawa M; Sasajima Y; Tsuda H
    J Obstet Gynaecol Res; 2012 Oct; 38(10):1260-5. PubMed ID: 22563932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma.
    Gadducci A; Ferdeghini M; Prontera C; Giordano P; Cristofani R; Bianchi R; Fioretti P
    Eur J Gynaecol Oncol; 1990; 11(4):283-8. PubMed ID: 2245812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma.
    Tabata T; Takeshima N; Tanaka N; Hirai Y; Hasumi K
    Tumour Biol; 2000; 21(6):375-80. PubMed ID: 11006578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix.
    Hong JH; Tsai CS; Wang CC; Lai CH; Chen WC; Lee SP; Chang TC; Tseng CJ
    Chang Gung Med J; 2000 Jul; 23(7):396-404. PubMed ID: 10974754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
    Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
    Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Yang SN; Lin FJ
    Tumour Biol; 2008; 29(4):255-61. PubMed ID: 18781097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.